Immunosuppressive or Surgical Treatment for Ocular Myasthenia Gravis
- 1 December 2007
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 64 (12), 1792-1794
- https://doi.org/10.1001/archneur.64.12.1792
Abstract
Opinion from JAMA Neurology — Immunosuppressive or Surgical Treatment for Ocular Myasthenia GravisThis publication has 17 references indexed in Scilit:
- The effect of prednisone on the progression from ocular to generalized myasthenia gravisJournal of the Neurological Sciences, 2004
- Myasthenia Gravis (MG): Epidemiological Data and Prognostic FactorsAnnals of the New York Academy of Sciences, 2003
- Development of Generalized Disease at 2 Years in Patients With Ocular Myasthenia GravisArchives of Neurology, 2003
- Immunosuppressive Treatment of Ocular Myasthenia GravisBioDrugs, 2001
- SFEMG in ocular myasthenia gravis diagnosisClinical Neurophysiology, 2000
- The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick childrenOphthalmology, 2000
- Ocular myasthenia gravis: response to long-term immunosuppressive treatment.Journal of Neurology, Neurosurgery & Psychiatry, 1997
- A multicentre follow-up study of 1152 patients with myasthenia gravis in ItalyZeitschrift für Neurologie, 1990
- Ocular myasthenia: diagnostic and therapeutic problemsActa Neurologica Scandinavica, 1988
- The Course of Myasthenia Gravis and Therapies Affecting OutcomeaAnnals of the New York Academy of Sciences, 1987